Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500115774Phase 4Not yet recruiting
Phase 4, randomised trial of dexmedetomidine in postpartum depression (PPD), Insomnia and sleep disorder (2 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoints: PSQS score on the first day after delivery and EPDS score on the 42 days after delivery. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500115774.